TPO agonist 1 is a thrombopoietin (TPO) receptor agonist that promotes thrombopoiesis and megakaryocytopoiesis; it can be used in the research of thrombocytopenia; TPO receptor agonists are novel treatments for patients with chronic immune thrombocytopenia (ITP), aimed at increasing platelet production through interaction with the TPO receptor on megakaryocytes, thereby increasing platelet counts, decreasing bleeding events, and reducing the need for adjunctive or rescue therapies.